INSIDER
FDA says pause of Johnson & Johnson COVID-19 vaccine to investigate rare clots to last ‘matter of days’
Read full article: FDA says pause of Johnson & Johnson COVID-19 vaccine to investigate rare clots to last ‘matter of days’The FDA says the pause to the Johnson & Johnson COVID-19 vaccine to investigate rare blood clots is expected to last a “matter of days.”